Zero-Field MRI to Enhance Diagnosis of Neurodegeneration. Lurie D, Broche L, Counsell CE, Murray AD, Riedel G. EPSRC, £988,625 (FEC £1,247,106) 2013-2016.
Occupational profile and contribution to cognitive reserve. Murray AD, Staff RT, Whalley LJ & Phillips L. Pathways to a healthy life: Pump priming, £2,092, 2013-14.
Life-course determinants of resilience to cognitive decline and mood disorders. Murray AD, Phillips L, Black C, McArdle K. PhD Studentship, £54,570, 2013-2016.
Follow-up of dementia outcomes in the Aberdeen Birth Cohort of 1936 - Secondment for Professor LJ Whalley. Murray AD, £4,020, 2012-2013.
Retinol binding protein 4, brain imaging biomarkers of Alzheimer's disease and cerebrovascular disease, and cognitive decline. Murray AD, Delibegovic M, Staff RT, McNeil C. Tenovus Scotland, £9,839, 2012-2013.
Novel and Collaborative Approaches to Knowledge Exchange in Translational Imaging. SINAPSE, Pfizer, TMVS, Varian, GE healthcare, Siemens, GSK, ReNeuron, LUX Innovate, Propeller, NHS R&D, SHIL. SFC SPIRIT £2,249,194, 2010-2013.